Partnering for success

Beyond Curve’s pipeline and focus there are multiple applications for our disease agnostic Microcycle platform to revolutionize drug discovery, with clear opportunities for collaborative programs with partners that have a depth of knowledge in target biology and expertise in drug development.

Curve welcomes the opportunity to collaborate with pharma partners to identify novel hits and leads against their high-priority targets in a broad range of indications.